Keyphrases
Melanoma
63%
Melanoma Patients
49%
Psoriasis
37%
Metastatic Melanoma
35%
Atopic Dermatitis
27%
COVID-19 Pandemic
26%
COVID-19
22%
Italy
21%
Cutaneous T-cell Lymphoma
21%
Tyrosinase
19%
Actinic Keratosis
19%
Peripheral Blood
19%
Tyrosinase Expression
18%
Mycosis Fungoides
18%
Quantitative PCR
18%
Integrin
17%
Cutaneous Disease
16%
Tumor
16%
Basal Cell Carcinoma
16%
Skin Lesions
16%
Risk Factors
15%
Disease-free Survival
15%
Prognostic Relevance
15%
Skin Cancer
14%
Squamous Cell Carcinoma (SqCC)
14%
Primary Melanoma
14%
Solid Organ Transplant Recipients
14%
Malignant Melanoma
14%
Extracorporeal Photochemotherapy
13%
Ipilimumab
13%
Non-melanoma Skin Cancer
13%
Immunocompromised Patients
12%
Sentinel Lymph Node
12%
Immunosuppressive Therapy
12%
Multivariate Analysis
12%
Multiple Primary Melanoma
12%
Clinical Features
12%
CD4+
12%
Dupilumab
11%
Clinical Outcomes
11%
Overall Survival
11%
Kidney Transplant Recipients
11%
Quality of Life
11%
Disease Progression
11%
Metastasis
10%
Clinical Response
10%
Inflammatory Skin Diseases
10%
Single Center
10%
Melanoma Cells
10%
Microbiota
10%
Medicine and Dentistry
Melanoma
100%
COVID-19
36%
Psoriasis
34%
Diseases
28%
Metastatic Melanoma
26%
Neoplasm
25%
Dermatosis
25%
Tyrosinase
24%
Cutaneous T Cell Lymphoma
20%
Integrin
20%
Atopic Dermatitis
19%
Squamous Cell Carcinoma
19%
Disease Course
17%
Mycosis fungoides
17%
Actinic Keratosis
17%
Immunosuppressive Treatment
16%
Photopheresis
16%
Basal-Cell Carcinoma
16%
Lymphocyte
16%
Skin Defect
15%
Skin Cancer
15%
Immunosuppressive Drug
15%
Dermatitis
15%
Keratinocyte
15%
Metastatic Carcinoma
14%
Skin Metastasis
14%
Observational Study
14%
Skin Tumor
13%
Kidney Graft
13%
Sentinel Lymph Node
12%
Multivariate Analysis
12%
Side Effect
12%
Prevalence
12%
Cancer
11%
Disease Free Survival
11%
Melanoma Cell
11%
Skin Infection
10%
Systemic Therapy
10%
Psoriasis Vulgaris
10%
Overall Survival
10%
Messenger RNA
10%
Electrochemotherapy
10%
Melanoma Skin Cancer
10%
Cohort Study
9%
Scalp
9%
Reverse Transcription Polymerase Chain Reaction
9%
Quality of Life
8%
Disease Exacerbation
8%
Infection
8%
Prognostic Factor
8%